Global Chinese Business Club Overview
Global Chinese Business Club is a micro-cap Hong Kong foundation-works subcontractor that changed control in October 2025 and is attempting a transformation. All reported revenue still comes from the legacy business: excavation and lateral support (ELS) works, pile caps construction, and ancillary demolition, drainage, earthworks and structural steel works. That business is sold to main contractors on mostly public-sector projects. In FY2026 it generated HK$531.6m of revenue at a 4.4% gross margin and HK$11.0m of net profit. Since October 2025 the new controller, Mainland entrepreneur Zhou Zhenlin, has renamed the company and replaced the board. He has announced pivots into Hong Kong securities brokerage (a 33% associate), Mainland medical aesthetics and wellness, and an O2O e-commerce platform, none of which has yet produced revenue. The share price rose more than forty-fold in nine months and then fell about two-thirds in July 2026. That move, together with an SFC high-concentration warning, makes the equity a speculative, governance-sensitive situation rather than a fundamentally anchored construction stock.
Company's own description (FY2026 Annual Report, paraphrased)
The FY2026 Annual Report (published 31 July 2026) describes the Group as a Hong Kong subcontractor providing foundation-related services. These are ELS works and pile caps construction, plus other services: demolition, underground drainage, earthworks and structural steelworks. To a lesser extent the Group leases machinery to other construction companies. The Report of the Directors lists four principal activities for the subsidiaries:
-
(i) foundation works and construction machinery rental;
-
(ii) financial services;
-
(iii) medical and healthcare services;
-
(iv) e-commerce platform services.
The segment note in the same accounts states that the Group has one operating segment, foundation works in Hong Kong. Only activity (i) generated revenue in FY2026.
Independent characterization
In economic terms, the company is a labour- and plant-intensive second-tier specialist subcontractor. Its customers are main contractors and other construction companies working on public and private projects in Hong Kong.
Revenue model.
-
100% of FY2026 revenue (HK$531.6m) is construction-contract service revenue recognised over time using an output method. Progress is based on the value of work certified by independent quantity surveyors.
-
There is no product, subscription or licensing revenue.
-
Secondary income is booked as "other income", not revenue. It consists of sales of construction waste (HK$7.7m in FY2026) and machinery rental and transportation income (HK$3.3m in FY2026).
Value-chain position. The company sits below the main contractor and above its own sub-subcontractors. FY2026 subcontracting fees were HK$157.2m, 30.9% of cost of services. Owned plant (PP&E of HK$19.5m net at 31 March 2026) is a competitive input. Pricing is set project by project according to scope and complexity, so margins depend on project mix. Gross margins have ranged from 1.2% to 4.4% over FY2022–FY2026.
Customer types.
-
Main contractors on public works, which accounted for 86.6% of FY2026 revenue (HK$460.4m).
-
Main contractors on private-sector projects, which accounted for 13.4% (HK$71.3m).
-
Concentration is extreme. The largest customer accounted for 33.0% of FY2026 revenue (54.3% in FY2025). The five largest accounted for 85.0% (100.0% in FY2025). Five customers each exceeded 10% of revenue in FY2026, with Customer A at HK$167.2m.
End-markets. Hong Kong public infrastructure and housing (sites cited include Tung Chung, Kai Tak, Siu Lam, Hung Hom, Tseung Kwan O, Fanling and Anderson Road) and private residential and commercial development.
Prospective businesses (announced, pre-revenue as of FY2026):
Financial services: an indirect 33% interest in a Hong Kong company licensed by the SFC for Type 1 regulated activity (dealing in securities). Completed April 2026.
Medical and healthcare (Mainland China): - Medical aesthetics: integrating expert teams, establishing high-end medical aesthetic hospitals, and working with regenerative-medicine institutions.
- Healthcare and wellness: a planned nationwide chain of wellness stores intended to form a "closed-loop" ecosystem.
E-commerce (Mainland China): an O2O platform combining multi-category transactions, big-data supply-chain management, social-commerce and live-streaming marketing, and B2B/B2C integration.
Strategy
Stated strategic themes (FY2026 Chairman's Statement and MD&A, paraphrased)
-
Core business: discipline over growth. Keep the focus on foundation works, be more selective about projects to raise margins, and maintain cost control, operational efficiency and risk management. Expand service capability and market share where possible.
-
Strategic diversification into "new growth engines".
-
Financial services through the 33% broker stake.
-
Mainland medical aesthetics and health and wellness, positioned as aligned with national policies on consumption upgrading and population ageing.
-
An O2O e-commerce platform.
-
-
Ecosystem-building through deals. Strategic investment, cooperation and M&A to connect partners along the medical and healthcare value chain, building an "open, collaborative" industrial platform.
-
Market risk mitigation (legacy). Reduce reliance on government projects by bidding for more private work, and plan new machinery fleets.
Initiative register (last 24 months)
| Date | Initiative | Type | Targets / commitments | Status |
|---|---|---|---|---|
| 15 Oct 2025 | Change of control to China VC | Ownership | — | Completed |
| Jan–Feb 2026 | Rebrand to Global Chinese Business Club | Corporate identity | — | Completed |
| 13 Mar 2026 | China integrated O2O e-commerce platform | New business launch | No financial targets disclosed | In development; no revenue |
| 19 Mar 2026 | 33% indirect stake in SFC Type 1 licensed broker | Investment / new business | Consideration not disclosed; HK$1.37m contracted capital commitment at 31 Mar 2026 | Completed Apr 2026 |
| FY2026 (MD&A); 4 Jun 2026 update | Medical aesthetics hospitals; health & wellness store chain; TCM wellness | New business launch | No capex or revenue targets disclosed | Pre-revenue |
| 25 Mar 2026 | Board lot cut to 1,000 shares | Liquidity measure | — | Completed |
| 5 Aug 2026 | CTO and CMO appointments (Peng, Guo) | Leadership | — | Completed |
| 24 Aug 2026 | New corporate logo | Branding | — | Completed |
| 28 Sep 2026 | AGM general mandates to issue and repurchase shares | Capital flexibility | Standard mandate limits | Approved (poll results filed) |
Guidance and medium-term targets
-
No medium-term financial targets have been published.
-
The only quantitative guidance was the 5 May 2026 positive profit alert: FY2026 profit of HK$8–12m. The actual result was HK$11.0m.
-
Qualitatively, management is "cautiously optimistic" that results can stay stable or improve.
ESG/sustainability commitments: generic (energy-saving equipment, waste reduction). No quantified targets.
Products & Services
The company does not disclose product-level revenue, pricing or brands. The catalog below is built from service descriptions in the FY2022–FY2026 annual results and the FY2026 Annual Report.
Product Portfolio
| Segment | Service / offering | Description & capabilities | Target customer | Launch / latest | Pricing model |
|---|---|---|---|---|---|
Foundation works | Excavation & lateral support (ELS) works | Bulk excavation with temporary earth-retaining systems so that basements and pile caps can be built; uses owned excavators and plant | Main contractors (public/private) | Core since inception; ongoing | Contract sum by scope and complexity; progress-billed against QS-certified work |
Foundation works | Pile caps construction | Reinforced-concrete caps tying piles to superstructure | Main contractors | Core; ongoing | Contract-based, progress billing |
Other services | Demolition works | Removal of existing structures ahead of foundation works | Main contractors | Ongoing | Contract-based |
Other services | Underground drainage works | Below-ground drainage installation | Main contractors | Ongoing | Contract-based |
Other services | Earthworks | Site cut/fill and soil handling | Main contractors | Ongoing | Contract-based |
Other services | Structural steelworks | Steel elements associated with foundation/ELS structures | Main contractors | Ongoing | Contract-based |
Ancillary (other income) | Machinery leasing & transportation | Leases owned construction machinery to other contractors (HK$3.3m in FY2026) | Other construction companies | Ongoing | Rental rates (not disclosed) |
Ancillary (other income) | Sale of construction waste | Monetisation of excavated/waste materials (HK$7.7m in FY2026) | Recyclers/buyers (not disclosed) | Ongoing | — |
Financial services (associate) | Securities dealing (SFC Type 1) | 33% indirect stake in a licensed HK broker; broker's name not disclosed in filings reviewed | Retail/corporate investors | Completed Apr 2026 | Commission-based (inferred, not disclosed) |
Medical & healthcare (planned) | Medical aesthetics ecosystem | High-end medical aesthetic hospitals; expert teams; regenerative medicine collaborations | Mainland consumers | Announced FY2026; pre-revenue | — |
Medical & healthcare (planned) | Healthcare & wellness store chain; TCM wellness | Nationwide store clusters; upstream/downstream integration | Mainland consumers (ageing demographic) | Announced FY2026; progress update 4 Jun 2026 | — |
E-commerce (planned) | Integrated O2O e-commerce platform | Multi-category trading; big-data supply chain; social commerce and live-streaming; B2B+B2C closed loop | Mainland suppliers and consumers | Announced 13 Mar 2026; pre-revenue | — |
“—” = not publicly disclosed.
| Metric | FY2022 | FY2024 | FY2026 |
|---|---|---|---|
Projects on hand (number) | 19 | 19 | 34 |
Total original contract sum of projects on hand (HKD Mn) | 1,600 | 1,200 | 1,400 |
New contracts awarded in year (number) | 5 | 9 | 15 |
New contract value awarded (HKD Mn) | 296.0 | 268.0 | 405.0 |
Projects completed in year (number) | 3 | 4 | 5 |
Value of projects completed (HKD Mn) | 27.0 | 100.1 | 169.9 |
Financial Narrative
All figures are HK$ millions unless stated. Fiscal years end 31 March. Sources:
-
FY2022 annual results announcement (17 Jun 2022)
-
FY2024 annual results announcement (27 Jun 2024), with FY2023 comparatives
-
FY2026 annual results announcement (29 Jun 2026), with FY2025 comparatives
Operating income is defined as profit before tax plus finance costs. EBITDA is operating income plus depreciation.
Income statement
FY2025 "other income" excludes a HK$0.06m loss on disposal. FY2026 other income excludes a HK$0.87m disposal gain, which is included in EBIT.
Margins
Revenue CAGR:
-
FY2022→FY2026 (4 years): +0.97% p.a.
-
FY2021→FY2026 (5 years, from HK$446.8m): +3.5% p.a.
The flat long-run trend hides very large year-to-year swings: −36%, −39%, +21%, +121%.
Commentary (income statement).
- FY2026 is the first year since FY2018 with a meaningful profit. Three things drove it: revenue more than doubled, gross margin reached a five-year high of 4.4%, and administrative costs fell for a third straight year to HK$18.6m.
FY2023–FY2025 profits were mostly non-operating: - Other income (construction-waste sales, machinery rental, and in FY2023 HK$5.6m of COVID-19 ESS grants) was 3–4× gross profit.
- ECL reversals and tax credits supplied the rest. FY2024's HK$2.4m profit included a HK$1.8m prior-year tax over-provision.
FY2026 profit is of higher quality,: coming from gross profit rather than from these items. It still carried a HK$1.9m ECL charge, against a HK$0.3m reversal the year before.
- The EBITDA margin was stable at 4.4–5.1% across FY2023–FY2026. Falling depreciation (from HK$14.8m in FY2023 to HK$8.8m in FY2026) reflects an ageing, shrinking fleet. It does not reflect efficiency gains.
Finance costs are largely non-cash: In FY2026, HK$1.22m of HK$1.33m was imputed interest on the interest-free former-director loan.
Staff costs are the dominant cost line: They rose 35% to HK$116.8m in FY2026 (FY2025: HK$86.4m). Subcontracting fees tripled to HK$157.2m (FY2025: HK$52.7m), consistent with a volume surge executed partly through subcontractors.
Balance sheet (as at 31 March)
Notes:
-
"Debt" consists almost entirely of amounts due to the former controlling shareholder Mr. Chan Siu Cheong (HK$26.8m at 31 Mar 2026), plus lease liabilities and a bank overdraft (HK$2.0m at FY2025 only).
-
The Group has had no bank borrowings since FY2022.
-
No goodwill or intangibles were recognised through 31 March 2026. The April 2026 associate acquisition will appear in FY2027.
Commentary (balance sheet).
The balance sheet is small and dominated by working capital: Receivables plus contract assets of HK$195.8m make up 85% of total assets.
- Contract assets (including retentions) rose 35% to HK$126.0m in FY2026 as volumes surged. Advance payments to subcontractors fell from HK$63.9m to HK$24.4m.
Equity grew HK$12.1m to HK$101.3m: This reflects the profit plus a HK$1.1m deemed capital contribution from re-measuring the renewed director loan.
Liquidity depends on the former controller's loan: Cash covered only 38% of the HK$26.8m due to Mr. Chan, all of which was classified as current. The HK$31.5m principal was repayable by 26 September 2026. Whether it was repaid, refinanced or extended after the change of control is a key unresolved item; no announcement was retrieved.
The new controller has not injected equity: No placing or rights issue has taken place since the 2018 IPO.
Cash flow
The full cash-flow statements are on pp. 116–117 of the FY2026 Annual Report and in prior annual reports. Indirect evidence:
-
Cash rose HK$4.4m in FY2026, and the director-loan balance fell HK$7.1m.
-
Implied combined operating and investing inflow is therefore roughly HK$11–14m before lease payments. This is an estimate, not a reported figure.
-
No dividends or buybacks were paid in any year (Reports of the Directors, FY2022–FY2026).
Ratios
Notes:
-
The proxy cash conversion cycle is (trade receivables + contract assets) days minus trade payable days. There is no inventory.
-
All ratios are analyst calculations from the filed statements.
-
FY2021 opening balances (equity HK$77.8m; total assets HK$202.0m) were used for FY2022 averages.
Ratio commentary. FY2026 is an inflection on every return metric: ROE 11.6%, ROIC 10.0%, interest cover 11×, net debt/EBITDA below 1×.
Two caveats temper this:
-
One year of evidence. The prior four years averaged an ROE of about 2%.
-
Working-capital release is unlikely to repeat. FY2026's 82-day cycle improved from 107 days mainly because subcontractor advances were released and invoicing was faster. Payable days, however, collapsed from 66 to 27. That suggests the company paid subcontractors faster, possibly at a changed relationship with its dominant subcontractor (85.4% of subcontracting charges in FY2026).
Earlier history (context)
Sources: FY2019 results announcement; FY2022 results announcement (FY2021 comparatives); FY2020 revenue from TipRanks (aggregator).
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Segment Overview
| Segment | Contents | Products/services | Status |
|---|---|---|---|
Foundation works (Hong Kong) | — | ELS works, pile caps construction, demolition, underground drainage, earthworks, structural steelworks; machinery leasing (as other income) | Sole revenue segment |
Financial services (associate) | 33% of a BVI company wholly owning an SFC Type 1 licensed HK broker | Securities dealing | Equity-accounted from Apr 2026; no FY2026 contribution |
Medical & healthcare (planned) | — | Medical aesthetics hospitals; wellness store chain; TCM wellness | Pre-revenue |
E-commerce (planned) | — | O2O multi-category platform | Pre-revenue |
“—” = not publicly disclosed.
Results by Segment and Segment Margins & Growth (%)
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Foundation works revenue (HKD Mn) | 511.6 | 326.5 | 199.3 | 240.8 | 531.6 |
Segment gross profit (HKD Mn) | 18.9 | 4.0 | 4.6 | 8.5 | 23.3 |
Segment gross margin (%) | 3.7 | 1.2 | 2.3 | 3.5 | 4.4 |
Segment pre-tax profit (HKD Mn, = group) | 2.7 | 0.2 | 0.2 | 0.8 | 13.3 |
Revenue YoY growth (%) | 14.5 | -36.2 | -38.9 | 20.8 | 120.8 |
Contribution to total revenue (%) | 100 | 100 | 100 | 100 | 100 |
Revenue by Segment and Revenue by Segment (%)
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Public sector projects revenue (HKD Mn) | 291.4 | 315.0 | 145.6 | 237.0 | 460.4 |
Private sector projects revenue (HKD Mn) | 220.2 | 11.5 | 53.8 | 3.8 | 71.3 |
Public sector share of revenue (%) | 57.0 | 96.5 | 73.0 | 98.4 | 86.6 |
Private sector share of revenue (%) | 43.0 | 3.5 | 27.0 | 1.6 | 13.4 |
Public sector YoY growth (%) | 130.6 | 8.1 | -53.8 | 62.8 | 94.3 |
Private sector YoY growth (%) | -31.3 | -94.8 | 368.0 | -92.9 | 1,777.3 |
Income Statement and Per-Share Data
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Revenue (HKD Mn) | 511.6 | 326.5 | 199.3 | 240.8 | 531.6 |
Cost of services (HKD Mn) | 492.7 | 322.5 | 194.8 | 232.3 | 508.3 |
Gross profit (HKD Mn) | 18.9 | 4.0 | 4.6 | 8.5 | 23.3 |
Other income (HKD Mn) | 5.8 | 17.5 | 15.5 | 13.0 | 11.0 |
Administrative expenses (HKD Mn) | 21.8 | 22.3 | 21.5 | 19.4 | 18.6 |
ECL reversal/(impairment), net (HKD Mn) | 0.2 | 1.9 | 3.1 | 0.3 | -1.9 |
Operating income / EBIT (HKD Mn) | 3.1 | 1.0 | 1.7 | 2.4 | 14.6 |
Depreciation (HKD Mn) | 13.3 | 14.8 | 8.3 | 9.2 | 8.8 |
EBITDA (HKD Mn) | 16.4 | 15.8 | 10.1 | 11.6 | 23.5 |
Finance costs (HKD Mn) | 0.4 | 0.8 | 1.5 | 1.6 | 1.3 |
Pre-tax income (HKD Mn) | 2.7 | 0.2 | 0.2 | 0.8 | 13.3 |
Income tax credit/(expense) (HKD Mn) | 0.3 | 0.6 | 2.2 | 0.3 | -2.3 |
Net income attributable (HKD Mn) | 3.0 | 0.8 | 2.4 | 1.1 | 11.0 |
EPS basic (HK cents) | 0.25 | 0.07 | 0.20 | 0.09 | 0.92 |
EPS diluted (HK cents) | 0.25 | 0.07 | 0.20 | 0.09 | 0.92 |
Dividends per share (HK cents) | 0 | 0 | 0 | 0 | 0 |
Margin Analysis (%)
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Gross margin (%) | 3.69 | 1.22 | 2.29 | 3.52 | 4.39 |
Operating (EBIT) margin (%) | 0.61 | 0.32 | 0.87 | 0.98 | 2.75 |
EBITDA margin (%) | 3.21 | 4.84 | 5.05 | 4.82 | 4.41 |
Net margin (%) | 0.58 | 0.25 | 1.22 | 0.44 | 2.08 |
Income Statement and Operating Metrics (number)
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Staff costs incl. directors (HKD Mn) | 88.6 | 88.7 | 72.1 | 86.4 | 116.8 |
Subcontracting charges (HKD Mn) | 146.2 | 103.6 | 69.3 | 52.7 | 157.2 |
Auditor remuneration (HKD Mn) | 1.04 | 0.91 | 0.75 | 0.75 | 0.85 |
Employees at year end (number) | 129 | 112 | 113 | 115 | 146 |
Revenue per employee (HKD Mn) | 3.97 | 2.92 | 1.76 | 2.09 | 3.64 |
Balance Sheet and Margin Analysis (%)
| Metric | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Total assets (HKD Mn) | 222.8 | 214.2 | 224.1 | 221.1 | 229.7 |
Property, plant & equipment (HKD Mn) | 30.7 | 26.1 | 24.4 | 21.9 | 19.5 |
Trade & other receivables (HKD Mn) | 41.5 | 74.2 | 104.1 | 96.5 | 69.7 |
Contract assets (HKD Mn) | 135.3 | 94.6 | 86.5 | 93.2 | 126.0 |
Cash & equivalents (HKD Mn) | 11.9 | 17.2 | 3.9 | 5.7 | 10.1 |
Short-term debt incl. director loan, overdraft, leases (HKD Mn) | 41.8 | 14.0 | 12.9 | 38.8 | 29.3 |
Long-term debt incl. director loan, leases (HKD Mn) | 1.2 | 28.4 | 31.4 | 0.4 | 1.8 |
Total debt (HKD Mn) | 43.0 | 42.5 | 44.3 | 39.2 | 31.1 |
Net debt (HKD Mn) | 31.1 | 25.2 | 40.4 | 33.5 | 21.0 |
Total equity (HKD Mn) | 80.8 | 85.7 | 88.1 | 89.1 | 101.3 |
Goodwill & intangibles (HKD Mn) | 0 | 0 | 0 | 0 | 0 |
Working capital / net current assets (HKD Mn) | 52.1 | 89.5 | 93.1 | 67.6 | 82.6 |
Reported gearing ratio (%) | 53.3 | 49.6 | 50.3 | 41.8 | 30.7 |
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansCash Flow
| Item | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Capex (HKD Mn, per MD&A) | 10.6 | — | 4.6 | — | 3.6 |
Free cash flow | Not computable | Not computable | Not computable | Not computable | Not computable |
Dividends paid (HKD Mn) | 0 | 0 | 0 | 0 | 0 |
Share buybacks (HKD Mn) | 0 | 0 | 0 | 0 | 0 |
Returns & Leverage Ratios (%) and Financial Ratios (x)
| Ratio | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
ROE (%, on average equity) | 3.73 | 0.97 | 2.79 | 1.19 | 11.59 |
ROA (%, on average assets) | 1.39 | 0.37 | 1.11 | 0.47 | 4.90 |
ROIC (%, NOPAT at 16.5% / year-end equity+net debt) | 2.33 | 0.78 | 1.12 | 1.60 | 10.00 |
Current ratio (x) | 1.38 | 1.93 | 1.92 | 1.53 | 1.67 |
Debt / equity (x) | 0.53 | 0.50 | 0.50 | 0.44 | 0.31 |
Net debt / EBITDA (x) | 1.89 | 1.60 | 4.01 | 2.89 | 0.89 |
Interest coverage, EBIT / finance costs (x) | 7.0 | 1.3 | 1.2 | 1.5 | 11.1 |
Asset turnover (x, revenue / average assets) | 2.41 | 1.49 | 0.91 | 1.08 | 2.36 |
Receivable days incl. contract assets (days) | 107 | 121 | 206 | 173 | 110 |
Trade payable days on cost of services (days) | 31 | 47 | 65 | 66 | 27 |
Proxy cash conversion cycle (days) | 76 | 74 | 141 | 107 | 82 |
Income Statement
| Metric | FY2018 | FY2019 | FY2020 | FY2021 |
|---|---|---|---|---|
Revenue (HKD Mn) | 367.2 | 400.1 | 213.1 | 446.8 |
Gross profit (HKD Mn) | 40.7 | -42.4 | — | 8.9 |
Pre-tax income (HKD Mn) | 21.6 | -67.8 | — | 1.4 |
Net income (HKD Mn) | — | — | — | 0.65 |
Revenue by Region and Region Margins & Growth (%)
| Region | FY2022 | FY2023 | FY2024 | FY2025 | FY2026 |
|---|---|---|---|---|---|
Hong Kong revenue (HKD Mn) | 511.6 | 326.5 | 199.3 | 240.8 | 531.6 |
Mainland China revenue (HKD Mn) | 0 | 0 | 0 | 0 | 0 |
Rest of world revenue (HKD Mn) | 0 | 0 | 0 | 0 | 0 |
Hong Kong YoY growth (%) | 14.5 | -36.2 | -38.9 | 20.8 | 120.8 |
Revenue History
| Fiscal year | Main revenue drivers (sites) | Direction | Stated reason |
|---|---|---|---|
FY2022 | Kai Tak, Anderson Road, Yin Ping Road; Tseung Kwan O excavation | Growth | Large projects in full swing; owned machinery used |
FY2023 | Kai Tak (low margin), Tseung Kwan O | Decline | Major projects winding down |
FY2024 | Fanling, Tung Chung (commencing) | Decline | Kai Tak and TKO completed; new projects only starting |
FY2025 | Kai Tak, Tseung Kwan O (low margin) | Recovery | Partial ramp |
FY2026 | Tung Chung, Kai Tak, Siu Lam, Hung Hom | Strong growth | Sizable projects in full swing; better margins at Tung Chung and Hung Hom |
Share Price & Returns
| Date | Close (HKD) | Event / note | Source |
|---|---|---|---|
15 Oct 2025 | 0.425 | Day of SPA (offer price HK$0.089) | SFC notice cited by company |
12 Jan 2026 | 5.87 | +1,281% vs 15 Oct 2025 | SFC notice |
21 Jan 2026 | 5.99 | +1,309% vs 15 Oct 2025 | SFC notice |
24 Feb 2026 | 10.90 | — | Stoxray |
23 Mar 2026 | 17.78 | P/B ≈239× | Simply Wall St |
22 May 2026 | 17.00 | Market cap ≈US$2.6bn | Stoxray |
30 Jun 2026 | 17.26 | Day after FY2026 results | Lixinger |
16 Jul 2026 | 14.70 | Pre-collapse | Lixinger |
20 Jul 2026 | 9.30 | — | Lixinger |
24 Jul 2026 | 5.80 | NED resignation filed | Lixinger |
3 Aug 2026 | 5.40 | Volatility ≈234% | Lixinger |
Early Oct 2026 (latest) | 5.09 | Latest observed | etnet |
Valuation Multiples
| Multiple | 1757 | HK construction / heavy-infrastructure reference |
|---|---|---|
Market cap (HKD Mn) | 6,108 | — |
Enterprise value (HKD Mn; mkt cap + debt 31.1 − cash 10.1) | 6,129 | — |
P/E (trailing, x) | 553 | ≈4.9 (Lixinger Hang Seng heavy-infra sub-industry, Aug 2026) |
EV/EBITDA (x) | 261 | — |
EV/Sales (x) | 11.5 | — |
P/B (x) | 60.3 | ≈0.27 (Lixinger); ≈0.8 industry, 12.6 peer average (Simply Wall St, Mar 2026) |
Dividend yield (%) | 0 | ≈5.0 (Lixinger sub-industry) |
Capital Markets
| Item | Status |
|---|---|
Analyst consensus | None; no sell-side coverage identified |
Dividend history & policy | No dividends declared FY2022–FY2026 (and none recommended FY2019 onward per filings reviewed); no formal policy disclosed |
Share issuance | No new shares since 2018 IPO; general issuance mandate proposed at 2026 AGM |
Credit ratings (Moody's/S&P/Fitch) | Not rated |
Debt maturity profile | Former-director loan HK$26.8m carrying amount (HK$31.5m principal) due by 26 Sep 2026; lease liabilities HK$2.5m current, HK$1.8m non-current; no bank borrowings |
Liquidity / free float | Free float 25% (300m shares); top 60 holders own 90.61% (22 Jun 2026); thin turnover (e.g., HK$1.3m traded on 3 Aug 2026 per Lixinger) |
Analyst Conclusions
Management guidance
-
No numeric guidance for FY2027.
-
Management expresses "cautious optimism" that the construction business can stay stable or grow profit, supported by HK$253.3m of unrecognised contract value (HK$146.3m due within 12 months).
-
New businesses are framed as long-term value creators with no revenue timeline.
Consensus expectations
None. There is no analyst coverage.
Analyst framing: HK$146.3m of backlog due within 12 months is about 28% of FY2026 revenue. Unless new awards match the FY2026 pace (HK$405m), FY2027 construction revenue is likely to decline materially from HK$531.6m. The likely contributors are:
-
in-period burn of new wins;
-
variation orders on the 34 projects on hand.
Bull case
-
Margin durability plus scale. If gross margin holds above 4% and annual awards stay near HK$400m, the core business can earn HK$8–12m a year without bank debt, as shown in FY2026.
-
Controller's operating credentials. Mr. Zhou controls a listed company (Junwea Group, 1920.HK) and has two decades in beauty and wellness. That makes a medical-aesthetics injection or asset acquisition plausible, and the listed shell's currency (≈HK$6bn market cap) gives large purchasing power.
-
Clean balance sheet as a platform. No bank debt, net debt/EBITDA of 0.89× and HK$101m of equity give flexibility. The broker associate adds a licensed financial-services foothold that is scarce and hard to replicate.
Bear case
-
Valuation detached from fundamentals. At 553× trailing P/E and 60× book, even a ten-fold profit increase would leave the stock above sector multiples. The July 2026 collapse (−61% in six sessions) shows how fragile the price is with 90% of shares in 60 hands.
-
Core business shrinking into FY2027. Backlog is down 30%, the fleet is ageing (capex HK$3.6m against depreciation of HK$8.8m), the founder-operator has left, and 85% customer concentration combine to point to revenue and margin compression.
-
Governance and funding overhang. The SFC concentration notice, combined chair/CEO, and an all-owner executive team are concerns. So are three auditors in roughly three years, a HK$31.5m loan from the departed controller due in September 2026, and AGM issuance mandates. Together they imply dilution or related-party transactions may be used to fund the pivots.
Key catalysts and monitorables (next 12 months)
| Timing | Catalyst / monitorable | Why it matters |
|---|---|---|
| Sep–Oct 2026 | Treatment of HK$31.5m former-director loan (due 26 Sep 2026) | Liquidity; signals Chan–Zhou relationship |
| By 30 Nov 2026 | Interim results, 6 months to 30 Sep 2026 | First read on post-FY2026 backlog burn and first equity-accounted broker contribution |
| Ongoing | New contract awards (value, margin, public/private mix) | Backlog replenishment |
| Ongoing | Announcements of medical/wellness or e-commerce acquisitions, including any connected transactions with Zhou-affiliated entities | Dilution, valuation and related-party risk |
| Ongoing | Use of the AGM share-issuance mandate (placings) | Dilution at elevated prices could recapitalise; at depressed prices, value-destructive |
| Ongoing | High Court MGO-acceptance case | Register rectification precedent; governance optics |
| Ongoing | SFC/HKEX follow-up on trading or concentration | Regulatory risk |
| Jun 2027 | FY2027 annual results | Test of FY2026 sustainability |
Analyst verdict
Global Chinese Business Club is two companies under one ticker.
The first is a small, cyclical Hong Kong foundation subcontractor. FY2026 was its best year since listing: HK$531.6m revenue, a 4.4% gross margin, HK$11.0m profit, and an ROE near 12%. These were earned with no bank debt and with gross profit, rather than subsidies or tax credits, driving profit. On a sector multiple of five to ten times earnings, or roughly book value, that business is worth perhaps HK$60–110m. Its forward trajectory is more likely down than up. Backlog fell 30% to HK$253m, only HK$146m of which converts in the next twelve months. The founder-operator who held customer relationships has left. Customer and subcontractor concentration remain extreme.
The second is a listed vehicle controlled by Mainland entrepreneur Zhou Zhenlin, who paid HK$80m for 75% in October 2025. It has been rebranded around a "global Chinese business club" concept and pointed at medical aesthetics, wellness, e-commerce and brokerage. None of these has generated revenue, budgets or named targets. The market value of about HK$6.1bn at HK$5.09 (after peaking near HK$18–19) therefore assigns roughly HK$6bn to this second company's prospects and to its use as acquisition currency.
The evidence for that value is thin and the governance signals are adverse:
-
an SFC concentration warning;
-
a mandatory offer priced about 79% below market;
-
a full board and auditor replacement within two months;
-
a recombined chair/CEO with an all-owner executive team;
-
a July 2026 price collapse with no disclosed trigger.
Our assessment is that the equity is speculative and not supported by fundamentals. The construction franchise justifies a small fraction of the current price. Any investment case rests entirely on yet-unseen transactions whose terms could just as easily dilute minorities as reward them. Prudent investors should wait for the interim results, the loan resolution, and concrete, independently valued deal terms before engaging.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Board of Directors
| Name | Title | Appointed | Age | Prior roles / background | Education |
|---|---|---|---|---|---|
Zhou Zhenlin (周振林) | Chairman, Executive Director, CEO (from 5 Aug 2026); Chairman of Nomination Committee | Chairman/ED 7 Jan 2026 | 45 (FY2026 AR) | Deputy GM, Shenzhen Jiameiran Technology (skincare/beauty devices) 2004–2011; President, Shenzhen Runfei Technology 2012–2017; Chairman, Tofuls International Holdings Group (health & wellness consulting) since 2017; Chairman, World Chinese Business (Guangdong) Technology since Jun 2023; Chairman, Shihua International Club since Nov 2023; Chairman, ED and controlling shareholder of Junwea Group (China) Co. Ltd (HKEX: 1920) | Executive DBA, University of Montpellier (Mar 2025); business administration course, Guangxi University (2003) |
Peng Yunying (彭運英) | Executive Director, Vice Chairlady, Chief Technology Officer | 5 Aug 2026 | 56 | 30+ years in product R&D and beauty-care operations; Vice Chairlady, Global Chinese Merchants Club (Guangdong) Co., Ltd; senior roles at Shenzhen beauty/technology firms; owns 15% of China VC | MBA, Wrexham University (2021) |
Guo Xianjiao (郭顯教) | Executive Director, Vice Chairman, Chief Marketing Officer | 5 Aug 2026 | 56 | Brand Director, Guangdong Jianlibao Group; President, Guangdong Tongfu Education Technology Group; owns 10% of China VC | MBA, Wuhan University (2009) |
Cheng Shing Yan (鄭承欣) | INED; Audit, Remuneration and Nomination Committee member (named Remuneration Committee chair in one AR table; see note) | 15 Jan 2026 | 51 | EY (2004–08), Baker Tilly HK (2009–10), SHINEWING (2010–16); CFO, Sanroc International (1660) group; INED of Putian Communication (1720) and Easy Smart (2442); former INED of 1676, 1413 | MA International Accounting, CityU HK; HKICPA, FCCA, ACG, HKCGI |
Tsoi Chi Hei (蔡志熙) | INED; Chairman of Audit Committee | 15 Jan 2026 | 38 | Poon & Co CPA, SHINEWING, KPMG (manager to Jan 2017); Financial Controller & Co. Sec., Noble Engineering Group (8445) since 2017 | HKICPA (CPA, 2014) |
Zhou Wencan (周文灿) | INED; Remuneration Committee chair (per AR committee table) | 15 Jan 2026 | 32 | Audit Manager, Asia Pacific (Group) CPAs Shenzhen (2015–24); Senior Manager, Zanda (Shenzhen) CPAs (2024–25) | PRC CPA |
Tsui Chun Hung (崔隽雄) | Company Secretary | 15 Jan 2026 | 38 | Company Secretary of Junwea Group (China) (1920) since 2019 | BA (First Class) Accounting, Edinburgh Napier; FCPA (HKICPA) |
Zhang Zhang (張章) | Non-executive Director (resigned; see note) | 15 Jan 2026 | 38 | BD Manager, Grande Capital (2024–25); VP, Starlight Culture Entertainment (1159) 2014–21; INED, Kingland Group (1751) | BFin, Beijing Technology & Business Univ.; MBA, St. John's University NY |
Board of Directors — Chan Siu Cheong
| Name | Former role | Departure |
|---|---|---|
Chan Siu Cheong (陳紹昌) | Founder-controller; Chairman & CEO | Resigned as Chairman 7 Jan 2026; as ED and CEO 15 Jan 2026. Remains creditor (HK$26.8m due at 31 Mar 2026) |
Sin Ka Pong (單家邦) | Executive Director | 15 Jan 2026 |
Chan Mei Po (陳美寶) | Executive Director | 15 Jan 2026 |
Ho Chi Wai (何志威) | INED, Audit Committee Chairman | 15 Jan 2026 |
Cheung Kwok Yan Wilfred (張國仁) | INED, Remuneration Committee Chairman | 15 Jan 2026 |
Lau Leong Ho (劉亮豪) | INED | 15 Jan 2026 |
Woo Yuen Ping (胡遠平) | Company Secretary | 15 Jan 2026 |
Governance Overview
| Item | Detail |
|---|---|
New EDs Peng and Guo | Director's fee of HK$8,000 per month each; 2-year service contracts, auto-renewing for 1 year (announcement 5 Aug 2026) |
Total staff costs including directors (FY2026) | HK$116.8m |
Equity incentives | Share Option Scheme (adopted 14 May 2018); no options ever granted; 120m shares (10%) available; scheme expires Jun 2028 |
Major Shareholders
| Holder | Shares | % of issued | Source / date |
|---|---|---|---|
China VC Holdings Ltd (Zhou 75% / Peng 15% / Guo 10%) | 900,000,000 | 75.00 | FY2026 AR (31 Mar 2026); 25 Jun 2026 announcement |
382 shareholders each holding >10,000 shares | 260,351,000 | 21.70 | 25 Jun 2026 voluntary announcement (as at 22 Jun 2026) |
Others (86 holders <10,000 shares plus unidentified) | 39,649,000 | 3.30 | Same |
Top 60 shareholders combined (incl. China VC) | 1,087,258,000 | 90.61 | Same |
Insider ownership (directors, via China VC) | 900,000,000 (deemed) | 75.00 | FY2026 AR |
Competitive Landscape
Key Competitors
| Competitor | HKEX code | Segment overlap | Latest revenue (verified) | Positioning vs 1757 |
|---|---|---|---|---|
Vicon Holdings | 3,878 | Design-and-build foundation (piling, ELS, pile caps), private sector | HK$236.7m (FY2026, YE 31 Mar 2026); backlog HK$163.9m | Private-sector piling specialist; now smaller than 1757 by revenue |
Ling Yui Holdings | 784 | Foundation main contractor/subcontractor (ELS, pile caps, piling, site formation), private sector | HK$214.5m (FY2025, YE 31 Mar 2025) | Private-sector focus; complementary rather than head-to-head on public works |
Unnamed 55-year-old HK foundation contractor (HKEX filing 31 Jul 2026, ref. 2026073101217) | — | Piling, ELS, pile caps, site formation | HK$217.9m (FY2026) | — |
Sheung Yue Group Holdings | 1,633 | Piling, ELS, pile caps, site formation (HK & Macau) | — | Broader piling capability |
Chinney Kin Wing Holdings | 1,556 | Foundation and site investigation | — | Larger, diversified foundation player |
Kingland Group Holdings | 1,751 | Foundation/site formation-related works | — | Peer subcontractor (note: former 1757 NED Zhang Zhang is an INED of 1751) |
Wan Kei Group | 1,718 | Foundation and ground investigation | — | Peer |
Seven Elements Investment (formerly Sanroc) | 1,660 | Site formation and excavation | — | Peer (INED Cheng Shing Yan is a Sanroc-group CFO) |
Build King Holdings | 240 | Civil engineering main contractor | — | Potential customer and competitor on integrated packages |
Private specialist subcontractors (unlisted) | — | ELS/excavation | — | Price competition in tenders |
“—” = not publicly disclosed.
Peer Comparison FY2026
| Metric | Global Chinese Business Club (FY2026) | Vicon Holdings (FY2026) | Ling Yui Holdings (FY2025) | Peer 55-yr contractor (FY2026) |
|---|---|---|---|---|
Revenue (HKD Mn) | 531.6 | 236.7 | 214.5 | 217.9 |
Revenue growth (%) | 120.8 | — | — | — |
Gross margin (%) | 4.4 | — | — | — |
Net margin (%) | 2.1 | — | — | — |
R&D intensity (%) | ~0 (not disclosed) | ~0 (not disclosed) | ~0 (not disclosed) | ~0 (not disclosed) |
Backlog at year end (HKD Mn) | 253.3 | 163.9 | — | 49.0 (approx., per filing) |
Recent Developments
--



